Speaker Series

About Speaker Series

Our Speaker Series is packed with inspiring individuals for those that are looking to expand their knowledge in today’s hot topics in various industries.  Hear it from experts who bring years of experience in their respective fields.

Upcoming events…

October 10, 2019 | Launching Your Silicon Valley Startup: An Insider’s Guide With Hillary Mickell

October 17, 2019 | Impact of Disinformation: Analyzing Ad Effectiveness With Dr. Amanda Welsh

October 23, 2019 | Future of Mobility: IoT and Connected Devices With Mamoun Abu-Samaha

November 7, 2019 | A Discussion of the Generic Drug Industry

October 10, 2019 | Launching Your Silicon Valley Startup: An Insider's Guide With Hillary Mickell

Learn secrets to start up success, the entrepreneur’s journey and how to create successful partnerships for your business.
Meet the Speaker

Hillary MickellHillary is the Regional Dean and CEO of Northeastern University in the San Francisco Bay Area. She has spent 20 years bringing major consumer products to market and building consumer brands. Hillary started her career in advertising, and then quickly made the leap to technology marketing at Microsoft. Her interest in consumer brands eventually led her to senior marketing and channel management positions at Netscape, Shutterfly and Yahoo! where she met Foodily co-founder Andrea Cutright.

 

>Register Here

October 17, 2019 | Impact of Disinformation: Analyzing Ad Effectiveness

This is an engaging conversation where you look at fake information and quantify how bad we think it is by analyzing its impact.

Here’s an example: Suppose you see an ad encouraging you to breathe air. This ad is phenomenally effective! 100% of the people who see it breathe air! But it is eminently clear that the ad is actually quite useless. We were all going to breathe air anyway. Simply being exposed to information is not at all the same thing as believing and embracing the information much less taking action as a result.

This session will examine how the information spreads via articles and tweets, how to measure the impact through proxy measures like likes, retweets, Facebook posts and correlate all of this to, for example, a company’s stock price. Contrast exposure to impact. Dr. Welsh will also discuss how the impact can vary by person, including a new experimental analytics technique from a company that creates AI bots based on consumer personas to test variation in impact.

Meet the Speaker
Amanda Welsh is a professor of the practice in the Master of Professional Studies in Analytics program. In addition to teaching, she focuses on expanding Northeastern’s collaborations with industry partners in analytics and digital research and supports the innovation and growth of analytics programs at the university’s West Coast campuses.

Dr. Welsh worked for 25 years at the intersection of big data and media, founding two data-driven start-ups—Integrated Media Measurement Inc. and Garageband.com—and serving as a Media Research Scientist at Google. Most recently, she was executive vice president, data science, for The Nielsen Company, designing and running a global data sharing program. She has published numerous articles and a book on data collection and privacy. An award-winning video game designer and a private pilot, Dr. Welsh is executive director of the nonprofit Foundation for Scholarly Culture and serves on the board of Raising a Reader, a national literacy/family engagement program. She lives in California and teaches in San Jose, CA, and online.

>Register Here

October 23, 2019 | Future of Mobility IoT and Connected Devices With Mamoun Abu-Samaha

Where is the Internet of Things going and how is it changing the world of mobile devices? According to Statista, the total installed base of Internet of Things (IoT) connected devices is projected to amount to 75.44 billion worldwide by 2025, a fivefold increase since 2015.

If you work and live in Silicon Valley, you already know how fast and furious things change around here. Don’t miss your chance to get an information head start! The IoT industry is the next wave of Internet technologies and expected to create hundreds of thousands of well-paying professional jobs.

Learn how mobility relates to IoT and what the future looks like for us, the consumers.

Meet the Speaker

Professor Samaha got his MSEE at Eindhoven University of Technology, in the Netherlands. He has extensive industrial experience. He worked for Hewlett Packard, as an Architect & Technology Strategist in corporate IT, as a Software Architect, and then became a Wireless and Mobility Chief Technology officer. Later, he worked for Motorola Mobility as their Enterprise Chief Technology Officer.

Currently he is Co-Founder, CEO & Chief Strategy Officer for MobWee Inc.. Professor Samaha’s areas of interest include: mobile security identity and authentication, mobile device management, mobile applications, Android, iOS, Windows mobile, enterprise architecture & security and workflow, process automation.

November 7, 2019 | A Discussion of the Generic Drug Industry

Generic drugs make up 90% of the American drug supply. (Source: New York Times, May 2019)

 

Many questions have been asked after hearing about issues related to the quality of generic medicines.
Led by Dr. Jared Auclair, Northeastern dives deep into what the industry considers current good manufacturing practices and how companies are ensuring consumers get safe and quality medicines.
  • What is a safe, effective and quality medicine?
  • How do we ensure safe, effective and quality medicines get to patients?
  • What are generic drugs?
  • Small molecule versus large molecule?
  • What is the generic drug industry like abroad; tales from and FDA inspector

Meet the Speaker

Jared R. Auclair is currently an associate teaching professor in the department of chemistry and chemical biology at Northeastern University.  In addition, Dr. Auclair is the Director of Biotechnology and Bioinformatics, as well as the Director of the Biopharmaceutical Analysis Training Laboratory, the Asia-Pacific Economic Cooperation Center of Regulatory Excellence in Biotherapeutics, and oversees the International Council for Harmonisation training.  These latter appointments allow Dr. Auclair to collaborate with both academic researchers, industry and government in the area of biopharmaceutical development and analysis.  He has expertise in mol. biology, protein biochemistry, analytical chemistry, protein crystallography, and biological mass spectrometry; and is interested in understanding the molecular mechanisms of neurodegenerative diseases as well as advancing diagnostics for Women’s health.

>Register Here